Full-Time

Customer Support Representative

Posted on 9/8/2026

Nivagen Pharmaceuticals

Nivagen Pharmaceuticals

51-200 employees

Develops, acquires, and markets generic drugs

Compensation Overview

$28 - $31.47/hr

+ Yearly bonus

Sacramento, CA, USA

In Person

Bachelor's

Category
Customer Experience & Support (1)
Required Skills
FDA Regulations
CRM
SAP Products
Quality Assurance (QA)
Customer Service

Get referred to Nivagen Pharmaceuticals

See people who can refer or advise you

Requirements
  • At least 2 years of customer service, account support, or order management experience.
  • Strong communication, problem-solving, and interpersonal skills.
  • Excellent organizational skills with strong attention to detail.
  • Proficiency with Microsoft Office Suite and customer relationship management and SAP systems.
  • Ability to manage multiple priorities in a fast-paced startup environment.
  • Professional demeanor and commitment to delivering exceptional customer service.
Responsibilities
  • Serve as the primary contact for customer inquiries regarding products, orders, pricing, availability, shipping, and account management.
  • Process and monitor customer orders accurately and efficiently through internal systems.
  • Coordinate with Operations, Quality Assurance, Production, Regulatory Affairs, and Logistics teams to resolve customer issues and provide timely updates.
  • Maintain detailed and accurate customer records, communications, and order documentation.
  • Communicate product availability, lead times, shortages, backorders, and shipment status to customers.
  • Investigate and resolve customer complaints, discrepancies, and service-related issues while maintaining a high level of professionalism.
  • Support onboarding of new customer accounts and assist with account setup documentation.
  • Ensure all customer interactions comply with Food and Drug Administration regulations, company policies, and applicable quality standards.
  • Escalate quality events, adverse event reports, product complaints, and compliance concerns according to established procedures.
  • Assist with customer surveys, reporting, and continuous improvement initiatives.
  • Contribute to the development of customer service processes and standard operating procedures as the organization grows.
  • Maintain a thorough understanding of company products, services, and regulatory requirements.
Desired Qualifications
  • Experience in pharmaceutical, healthcare, biotechnology, medical device, or regulated manufacturing environments.
  • Knowledge of 503B outsourcing for hospitals and/or wellness organizations, sterile compounding, injectables, or Food and Drug Administration-regulated operations.
  • Experience supporting hospitals, clinics, healthcare systems, surgery centers, or healthcare providers.
  • Bachelor's degree.
Nivagen Pharmaceuticals

Nivagen Pharmaceuticals

View

Nivagen Pharmaceuticals develops, acquires, and sells generic prescription drugs and OTC products for the North American market. It leverages global partnerships with FDA-approved manufacturing facilities to deliver high-quality, affordable products and collaborates with the world’s best CROs and CRAMs to develop and manufacture niche generics. The company supports small FDA-qualified manufacturers entering the U.S. market and differentiates itself through its ability to launch new generic products and its strong sales and marketing team, rather than relying on a single manufacturing or development approach. Revenue comes from product development, co-development, acquisitions, in-licensing, and providing sales and marketing services. Nivagen aims to grow its portfolio by forging CRO/CRAM partnerships, acquiring existing products, and expanding its product lineup to capture a larger share of the evolving generic and OTC market in North America.

Company Size

51-200

Company Stage

Growth Equity (Venture Capital)

Total Funding

$26M

Headquarters

Sacramento, California

Founded

2009

Get referred to Nivagen Pharmaceuticals

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • PAI acquired Nivagen on January 6, 2026, adding domestic sterile capacity.
  • PAI says the combined pipeline includes 30-plus sterile products for hospitals.
  • Hospitals still face injectable shortages, matching PAI's January 2026 strategy.

What critics are saying

  • California recalled Nivagen atorvastatin on September 24, 2024 after a tablet mix-up.
  • A zinc oxide recall from October 31, 2025 cites ongoing cGMP deviations.
  • FDA lists Nivagen's Sacramento outsourcing facility as uninspected, threatening approval and uptime.

What makes Nivagen Pharmaceuticals unique

  • Nivagen's Sacramento aseptic plant makes IV bags, vials, prefilled syringes, and cartridges.
  • It built over 20 ready-to-use injectables, complementing PAI's oral-liquid franchise.
  • Corbel's 2022 structured investment backed complex injectables and 505(b)(2) development.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Paid Time Off

401 (k) savings plan

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

-3%

2 year growth

-6%
PE Hub
Jan 6th, 2026
Olympus-backed PAI Pharma picks up Nivagen Pharmaceuticals

Olympus-backed PAI Pharma picks up Nivagen Pharmaceuticals. Headquartered in Greenville, South Carolina, PAI is a developer, manufacturer and marketer of oral liquid medicines. * Nivagen operates an aseptic manufacturing facility in Sacramento, California, designed to support the production of IV bags, vials, prefilled syringes, and cartridges * Nivagen was founded in 2009 PAI Pharma, which is backed by Olympus Partners, has acquired Nivagen Pharmaceuticals, Inc, a Sacramento, California-based pharmaceutical company. No financial terms were disclosed. Gain instant access to our expert editorial analysis and in-depth insight. Already have an account? Sign in.

Benzinga
Jan 6th, 2026
PAI Pharma acquires Nivagen to expand US sterile injectable manufacturing amid persistent drug shortages

PAI Pharma, a portfolio company of Olympus Partners, has acquired Nivagen Pharmaceuticals, a California-based pharmaceutical company specialising in ready-to-use sterile injectables. The deal expands PAI's domestic manufacturing capabilities and addresses persistent drug shortages in the US healthcare system. Nivagen operates a state-of-the-art aseptic manufacturing facility in Sacramento, producing IV bags, vials, prefilled syringes and cartridges. The company brings over 20 injectable products to complement PAI's existing sterile portfolio of approximately 10 products in development and four on the market. The acquisition aligns with growing efforts to reshore pharmaceutical production and reduce reliance on foreign supply chains. PAI Pharma was advised by Bourne Partners, Kirkland & Ellis and KPMG, whilst Olympus Partners provided backing for the transaction.

Private Equity Info
Aug 22nd, 2022
Corbel Capital Partners invests into Nivagen Pharmaceuticals, Inc.

Corbel Capital Partners invested in Nivagen Pharmaceuticals (Sacramento, CA, US), a specialty pharmaceuticals business that develops and sells generic and branded prescription drugs.